You’ve been here a long time and you still haven’t figured it out?
Let’s go through the list:
-Incompetent, first-time CEO with checked employment history and zero credibility among institutional biotech investors,
-Complacent, compliant board of directors,
-Company funded through vulture investor,
-Cherry picked data,
-Changing endpoints to make data look better,
-Goal post moving,
-Burying data for years on end,
-Missed timelines 100% of the time,
-Horrible communications that leave investors with more questions than answers,
-No pharma partnerships,
-Past stock promotion schemes,
-Current threat of class action lawsuits.
I’m sure I missed a few.
What is NOT going on:
-Manipulation by WS, FDA, pharma cabal to take shares lower so insty buddies can buy cheaper.
MAGA - MAKE ANAVEX GREAT AGAIN!
Good licks and DOG bless,